Ebpay生命医药出版社

      Ebpay生命

      102912

      论文已发表

      提 交 论 文


      注册即可获取Ebpay生命的最新动态

      注 册



      IF 收录期刊



      • 3.4 Breast Cancer (Dove Med Press)
      • 3.2 Clin Epidemiol
      • 2.6 Cancer Manag Res
      • 2.9 Infect Drug Resist
      • 3.7 Clin Interv Aging
      • 5.1 Drug Des Dev Ther
      • 3.1 Int J Chronic Obstr
      • 6.6 Int J Nanomed
      • 2.6 Int J Women's Health
      • 2.9 Neuropsych Dis Treat
      • 2.8 OncoTargets Ther
      • 2.0 Patient Prefer Adher
      • 2.2 Ther Clin Risk Manag
      • 2.5 J Pain Res
      • 3.0 Diabet Metab Synd Ob
      • 3.2 Psychol Res Behav Ma
      • 3.4 Nat Sci Sleep
      • 1.8 Pharmgenomics Pers Med
      • 2.0 Risk Manag Healthc Policy
      • 4.1 J Inflamm Res
      • 2.0 Int J Gen Med
      • 3.4 J Hepatocell Carcinoma
      • 3.0 J Asthma Allergy
      • 2.2 Clin Cosmet Investig Dermatol
      • 2.4 J Multidiscip Healthc



      更多详情 >>





      已发表论文

      脂毒性:2 型糖尿病的新视角

       

      Authors Chen B , Li T, Wu Y , Song L , Wang Y, Bian Y, Qiu Y, Yang Z

      Received 19 December 2024

      Accepted for publication 14 April 2025

      Published 24 April 2025 Volume 2025:18 Pages 1223—1237

      DOI http://doi.org/10.2147/DMSO.S511436

      Checked for plagiarism Yes

      Review by Single anonymous peer review

      Peer reviewer comments 2

      Editor who approved publication: Dr Rebecca Conway

      Biaohua Chen,1,2,* Tiangang Li,1,2,* Yingli Wu,1,2,* Liyun Song,1,2 Yinying Wang,1,2 Yao Bian,1,2 Yong Qiu,1,2 Zhongshan Yang1,2 

      1Yunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, People’s Republic of China; 2Engineering Research Center of Classic Formula Regulate Immunity in Chronic Disease Prevention and Treatment, Kunming, Yunnan, People’s Republic of China

      *These authors contributed equally to this work

      Correspondence: Yong Qiu; Zhongshan Yang, Yunnan University of Chinese Medicine, Kunming, 650500, People’s Republic of China, Tel +86 13987131491, +86 13529154210, Email chenxiaofeng_82@126.com; yangzhongshan@ynucm.edu.cn

      Abstract: Type 2 diabetes mellitus is a non-communicable metabolic disorder characterized by insulin resistance (IR) associated with defects in insulin production and secretion. Recent studies have shown that lipotoxicity, which is characterized by the abnormal accumulation of lipids in non-adipose tissues, leads to bodily dysfunction and metabolic disorders, thereby promoting the progression of T2DM. This process is mediated by the induction of endoplasmic reticulum (ER) stress, oxidative stress (OS), mitochondrial dysfunction, and inflammatory responses in pancreatic β-cells, ultimately leading to the activation of apoptosis pathways, which results in β-cell dysfunction and cell death. Furthermore, lipotoxicity interferes with insulin signaling pathways, which worsens IR. Current clinical approaches aimed at mitigating lipotoxicity-induced IR and β-cell dysfunction include the use of metformin, glucagon-like peptide-1 analogs, thiazolidinediones, and molecular chaperones, in addition to interventions such as caloric restriction and physical activity, which reduce fat accumulation in the pancreas and enhance β-cell function. Investigating the interplay between lipotoxicity and T2DM is essential for understanding the underlying disease mechanisms and providing new insights into prevention and therapeutic strategies. This review offers a comprehensive analysis of the mechanisms underlying lipotoxicity in T2DM, highlighting how these insights may drive future research and inform the development of novel treatment approaches.

      Keywords: type 2 diabetes mellitus, adipose tissue, lipotoxicity, insulin resistance

      Download Article[PDF]